Immunological Traits of Cryoablation in Combination Therapy of Cancer
DOI:
https://doi.org/10.15407/cryo29.04.297Keywords:
cryoablation, cancer stem cells, immune system, antigen, dendritic cellsAbstract
Cryoablation is a method of choice in treatment of solid tumors of different localization. In addition to the destruction of pathological tissue, the cryoablation causes to complex changes in the immune system. This paper briefly discusses the implementation of the abscopic effect after cryosurgery of tumors, as well as possible changes in the immune system that accompany it. The abscopic effect is achieved with a release of antigens from the destroyed cells, which trigger a cascade of immune reactions. This article summarizes the results of the combined use of cryoablation and immunotherapeutic methods, in particular adoptive therapy. The introduction of dendritic cells in combination with cryoablation can signiï¬cantly enhance antitumor immunity and reduces the risk of relapse.
Â
Probl Cryobiol Cryomed 2019; 29(4):Â 297-302
References
Ahmedov SM, Rahimi FK, Ahmedov SSh, et al. [Application of cryogenic temperatures in liver surgery]. Reports of the Academician of Sciences of the Republic of Tajikistan. 2016, 59 (11-12): 524-33. Russian.
Benzon B, Glavaris SA, Simons BW, et al. Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancer. Prostate Cancer Prostatic Dis. 2018; 21(1): 126−36. CrossRef
Bayjoo P, Rees RC, Goepel JR, Jacob G. Natural killer cell activity following cryosurgery of normal and tumour bearing liver in an animal model. J Clin Lab Immunol. 1991; 35(3): 129-32. PubMed
Buriak I, Fleck R, Fuller B, Stacey G. The cryoprotectant DMSO. Identifying problems and developing its safe and effective use. In: Abstracts of the 55th SLTB Scientific Conference, Oct. 2-4, 2019, Seville, Spain. Seville; 2019. p. 46.
Campbell DE, Tustin NB, Riedel E, et al. Cryopreservation decreases receptor PD-1 and ligand PD-L1 coinhibitory expression on peripheral blood mononuclear cell-derived T cells and monocytes. Clin Vaccine Immunol. 2009; 16(11): 1648-53. CrossRef
Cha JH, Yang WH, Xia W, et al. Metformin promotes antitumor immunity via endoplasmic-reticulum-associated degradation of PD-L1. Mol Cell. 2018; 71(4): 606-20. CrossRef
El-Ashmawy NE, El-Zamarany EA, Salem ML, et al. A new strategy for enhancing antitumor immune response using dendritic cells loaded with chemo-resistant cancer stem-like cells in experimental mice model. Mol Immunol. 2019;111: 106-17. CrossRef
Gallucci S, Chakhtoura M, Lee MH, Qiu CC. The metabolic modulator metformin affects the activation and survival of murine dendritic cell subsets. J Immunol [Internet] . 2019 [Cited 18.01.2019]; 202(1 Suppl): 180.17 Available from: https://www.jimmunol.org/content/202/1_Supplement/180.17
Goltsev A, Bondarovich N, Babenko N, Gaevskaya Yu. Freezing conditions determine the integrity of antigenic characteristics of cancer cells. Experimental Oncology. 2018; 40 (2): 159.
Goltsev AN, Bondarovich NA, Babenko NN, et al. Freezing conditions determine functional potential of tumor cells. Cryobiology. 2018; 85: 168. CrossRef
Goltsev AM, Bondarovych MO, Babenko NM, et al. Effect of different cryopreservation regimens on Ehrlich carcinoma growth. Cell Tissue Bank. 2019; 20(3): 411-21. CrossRef
Goltsev AN, Safranchuk OV, Bondarovich NA, et al. [Change in cryolability of cancer stem cells during in vivo culture of Ehrlich adenocarcinoma]. Fiziol Zh. 2011; 57(4): 68-76. Ukranian. CrossRef
Gulley JL, Madan RA, Pachynski R et al. Role of antigen spread and distinctive characteristics of immunotherapy in cancer treatment. J Natl Cancer Inst [Internet]. 2017 [cited 19.11.2019]; 109(4): djw261. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441294/pdf/djw261.pdf CrossRef
Hamad GG, Neifeld JP. Biochemical, hematologic, and immunologic alterations following hepatic cryotherapy. Semin Surg Oncol. 1998; 14(2): 122-8. CrossRef
Li X, Zhong Z, Liang S, et al. Effect of cryopreservation on IL-4, IFNgamma and IL-6 production of porcine peripheral blood lymphocytes. Cryobiology. 2009; 59(3):322-6. CrossRef
Lleo A, Rimassa L, Colombo M. Hepatotoxicity of immune check point inhibitors: Approach and management. Dig Liver Dis. 2019; 51(8):1074-8. CrossRef
Mahmoodi S, Nezafat N, Negahdaripour M, Ghasemi Y. A new approach for cancer immunotherapy based on the cancer stem cell antigens properties. Curr Mol Med. 2019; 19(1): 2-11. CrossRef
Paczulla AM, Rothfelder K, Raffel S, et al Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion. Nature. 2019; 572(7768): 254-9. CrossRef
Robilotto AT, Baust JM, Van Buskirk RG, et al. Temperature-dependent activation of differential apoptotic pathways during cryoablation in a human prostate cancer model. Prostate Cancer Prostatic Dis. 2013; 16(1): 41-9. CrossRef
Sabel MS. Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses. Cryobiology. 2009; 58(1): 1-11. CrossRef
Si TG, Wang JP, Guo Z. Analysis of circulating regulatory T cells (CD4+CD25+CD127-) after cryosurgery in prostate cancer. Asian J Androl. 2013;15(4):461-5. CrossRef
Sidana A. Cancer immunotherapy using tumor cryoablation. Immunotherapy. 2014; 6(1): 85-93. CrossRef
Soanes WA, Ablin RJ, Gonder MJ. Remission of metastatic lesions following cryosurgery in prostatic cancer: immunologic considerations. J Urol. 1970; 104(1): 154-9. CrossRef
Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med. 1973; 137(5): 1142-62. CrossRef
Tan W, Tang H, Jiang X. et al. Metformin mediates induction of miR-708 to inhibit self-renewal and chemoresistance of breast cancer stem cells through targeting CD47. J Cell Mol Med. 2019; 23(9): 5994-6004. CrossRef
Vermaelen K. Vaccine strategies to improve anti-cancer cellular immune responses. Front Immunol [Internet]. 2019 [cited 19.11.2019]; 10:8. Available from: www.ncbi.nlm.nih.gov/pmc/articles/PMC6349827/pdf/fimmu-10-00008.pdf CrossRef
Vijendren A, Yung M, Sanchez J. Occupational health issues amongst UK doctors: a literature review. Occup Med (Lond). 2015; 65 (7): 519-28. CrossRef
Xu P, Yin K, Tang X, et al. Metformin inhibits the function of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. Biomed Pharmacother [Internet]. 2019 [cited 07.11.2019]; 120: 109458. Available from: https://www.sciencedirect.com/science/article/pii/S0753332219336157 CrossRef
Yang X, Guo Y, Guo Z, et al. Cryoablation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Oncotarget. 2018; 10(41): 4180-91. CrossRef
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
